Similarly, in the streptozotocin (STZ)-induced type 2 diabetes rat model, Dio1 activity and mRNA expression level in rats recoved to control levels after administration of T3 treatment and increased significantly when T3 and insulin were co-administrated (51). The gene discussed is DIO1; the disease is type 2 diabetes mellitus.